Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Quten Research Institute, LLC
WARNING LETTER
•Quten Research Institute, LLC•November 17, 2020

Quten Research Institute, LLC – FDA Warning Letter, Nov 17, 2020

Record Details

The FDA issued a Warning Letter to Qunol following a November 2020 review of their website, qunol.com. The agency determined that claims made for Qunol Ultra CoQ10 and Qunol Extra Strength Turmeric establish them as unapproved new drugs under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act), as they are intended for disease treatment, cure, mitigation, or prevention. These products are not generally recognized as safe and effective, classifying them as "new drugs" under section 201(p) of the Act, which require prior FDA approval per sections 301(d) and 505(a) before interstate commerce introduction. Furthermore, the products are misbranded under section 502(f)(1) of the Act because they lack adequate directions for use, as their intended uses address conditions not amenable to self-diagnosis or treatment by a layperson. The introduction of these unapproved and misbranded drugs into interstate commerce violates sections 301(d), 505(a), and 301(a) of the Act. Qunol is required to take prompt corrective action and respond in writing within fifteen working days, detailing steps taken to address the violations and prevent recurrence, or provide justification if they believe their products are not in violation. Failure to comply may result in legal action, including seizure and injunction.

Company
Quten Research Institute, LLC
Inspection date
November 17, 2020
Product type
Food
Office
Division of Human and Animal Food Operations - East II
Person
  • Lori A. Holmquist (Director of Investigations Branch)
View Company Profile

ID · d9ea45d7-9908-4209-9e94-eb9c4b57b543

Violation Codes8
21 U.S.C. 331(a)21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(p)21 U.S.C. 331(d)21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 CFR 201.521 U.S.C. 353(b)(1)(A)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Quten Research Institute, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.